Breaking News, Collaborations & Alliances

Hovione and iBET Launch New Joint Venture, ViSync Technologies

Aims to develop innovative solutions to address the unmet technical needs of pharmaceutical companies in the cell and gene therapy space.

Author Image

By: Charlie Sternberg

Associate Editor

Hovione, a specialist integrated CDMO, and iBET (Instituto de Biologia Experimental e Tecnológica), a private not-for-profit research-intensive SME in the area of Biotechnology and Life Sciences, have established ​​​​​​ViSync Technologies as a jointly owned venture.     This new company, headquartered in the Lisbon area of Portugal, will aim to develop innovative solutions to address the unmet technical needs of pharmaceutical companies in the cell and gene therapy space, leveraging Hovione&#8...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters